Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor
Authors: Xiaohui Zhao
Xi Wang
Xinghua Li
Jinrong Zhu
Libing Song
Chuyong Lin
Aibin Liu
Journal: Molecular Cancer (2014)
Discipline: MOLECULAR BIOLOGY & GENETICS
Keywords: Acylglycerol kinase; breast cancer; oncogenic role; clinicopathological features; FOXO1 transactivity
Affiliations: State Key Laboratory of Oncology in Southern China, Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China. .

Abstract:  Background: Acylglycerol kinase (AGK) is reported to be overexpressed in multiple cancers. The clinical significance and biological role of AGK in breast cancer, however, remain to be established. Methods: AGK expression in breast cancer cell lines, paired patient tissues were determined using immunoblotting and Real-time PCR. 203 human breast cancer tissue samples were analyzed by immunochemistry (IHC) to investigate the relationship between AGK expression and the clinicopathological features of breast cancer. Functional assays, such as colony formation, anchorage-independent growth and BrdU assay, and a xenograft tumor model were used to determine the oncogenic role of AGK in human breast cancer progression. The effect of AGK on FOXO1 transactivity was further investigated using the luciferase reporter assays, and by detection of the FOXO1 downstream genes. Results: Herein, we report that AGK was markedly overexpressed in breast cancer cells and clinical tissues. Immunohistochemical analysis showed that the expression of AGK significantly correlated with patients' clinicopathologic characteristics, including clinical stage and tumor-nodule-metastasis (TNM) classification. Breast cancer patients with higher levels of AGK expression had shorter overall survival compared to patients with lower AGK levels. We gained valuable insights into the mechanism of AGK expression in breast cancer cells by demonstrating that overexpressing AGK significantly enhanced, whereas silencing endogenous AGK inhibited, the proliferation and tumorigenicity of breast cancer cells both in vitro and in vivo. Furthermore, overexpression of AGK enhanced G1-S phase transition in breast cancer cells, which was associated with activation of AKT, suppression of FOXO1 transactivity, downregulation of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 and upregulation of the cell cycle regulator cyclin D1. Conclusions: Taken together, these findings provide new evidence that AGK plays an important role in promoting proliferation and tumorigenesis in human breast cancer and may serve as a novel prognostic biomarker and therapeutic target in this disease. 

Retracted: No

PubPeer comments:
 Figure 1B contains two WB bands which appear more similar than expected, after manipulation of band stretching. ![file] , 
 Figure 5C and Figure 6B contains two WB bands which appear more similar than expected. ![file] , 
 #1 Dear Lecithocera Eumenopis Thanks for pointing this out. We are currently repeating these experiments and will response as soon as possible. Libing Song , 
 - *[above]* Fig 4A. - *[below]* Figs 2b, 6b from  MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma ([Sun et al 2015] ). ![file] - *[left]* Fig 4C (MCF-7 panels). - *[right]* Fig 3b from Sun et al (2015). ![file] , 
 - *[left]* Fig 6B D. - *[right]* Fig 7A from  MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2 STAT3-mediated EMT process ([Tao et al 2017] ). ![file] , 
 - *[left]* Fig 7A from  LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1 EMT signaling pathway ([Tao et al 2017] ). - *[right]* **Fig 6B**. ![file] , 
 - *[above]* Fig 1B. - *[below]* Fig 1b from  TRIP6 enhances stemness property of breast cancer cells through activation of Wnt u03b2-catenin ([Zhao et al 2020] ). ![file] ,